Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $89,309.41 -1.78%
Ethereum $2,967.03 -4.03%
BNB $874.18 -4.21%
Optimism $0.31 +0.35%
Arbitrum $0.18 -1.85%
Solana $127.47 -0.82%
Polygon $0.22 +2.77%
Cosmos $2.37 -1.43%
Avalanche $12.23 -2.30%

Bitcoin $89,309.41 -1.78%
Ethereum $2,967.03 -4.03%
BNB $874.18 -4.21%
Optimism $0.31 +0.35%
Arbitrum $0.18 -1.85%
Solana $127.47 -0.82%
Polygon $0.22 +2.77%
Cosmos $2.37 -1.43%
Avalanche $12.23 -2.30%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B